Global Protein Therapeutics Market Analysis
27-May-2012 | General Article (Non-News)
Within the global pharmaceutical industry, protein therapeutics has been enjoying the fastest growth for the past few years. Playing a significant role in the treatment of many major diseases, protein therapies have revolutionized the methodology followed by drugs. These therapies owe their high efficiency to their targeted approach, which avoids side effects on healthy organs to a great extent. The acceptance of the various protein therapies can be attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/global-protein-therapeutics-market-analysis.html
According to our new research report “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market is expected to grow at a CAGR of around 13% during 2012-2014. Various factors, such as introduction of new protein therapeutics and enhanced investments will contribute to the buoyant growth of this industry. Besides, augmentation in the number of clinical trials will surface the optimistic performance of the industry. Industry Analysis
Based on our in-depth analysis of the industry, we have identified the major segments in protein therapeutics market, which include Monoclonal antibody, Insulin, Interferon, G-CSF, coagulation factors etc. Amongst the segments, monoclonal antibody dominates the global protein therapeutics market and is expected to be at the top in future as well. This has been possible due to the large numbers of players that have been directing their efforts to develop innovative treatments using mAbs.
As per our research, fast growth in protein therapeutics will also strengthen other emerging sectors. Bio-generics will represent a key future growth segment as it will try to offset the loss of market revenue as a result of patent expirations of branded therapies. Additionally, the market trends studied in the report suggest that, a lot of research work in the segment would be targeting the immunogenicity issues related to the protein therapies.
The report provides extensive information and rational analysis of the global protein therapeutics market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understands the market structure and its progress in coming years. The forecasts presented in the report are based on the correlation between the market trends and drivers.
Table of Contents :
1. Analyst View
2. Global Protein Therapeutics Market
2.1 Market Analysis
2.1.1 Market Size
2.1.2 Proteins Therapeutic Market vs Pharmaceutical Market
2.1.3 Market Segmentation
2.2 Future Outlook (2012-2014)
3. Industry Performance
3.1 Monoclonal Antibodies (mAbs)
3.1.1 Market Size
3.1.2 By Application
3.1.3 Key Geographical Markets
3.1.4 Key Players and Drugs
3.1.5 Industry Analysis
3.1.6 Recent Developments
3.1.7 Future Outlook (2012-2014)
3.2 Erythropoietin (EPO)
3.2.1 Market Size
For more information kindly visit :
Global Protein Therapeutics Market Analysis
Or
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
https://twitter.com/#!/bharatbook
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
- The Geothermal Energy Market 2012-2022
- Adhesives and Sealants: Global Markets
- Dermatological Drugs: World Market Prospects 2012-2022
- The Electric and Range Extended Electric Light-Vehicle Report
- India Urban & Industrial Waste to Energy Market
- Understanding Russia's Regional Health Markets
- 2012 Deep Research Report on China Wind Bearing Industry
- Top 1000 Advertising Agents (European)
- HNWI Asset Allocation in Switzerland to 2016